MTR
Basic information
Region (hg38): 1:236795260-236921278
Links
Phenotypes
GenCC
Source:
- methylcobalamin deficiency type cblG (Definitive), mode of inheritance: AR
- methylcobalamin deficiency type cblG (Supportive), mode of inheritance: AR
- methylcobalamin deficiency type cblG (Strong), mode of inheritance: AR
- methylcobalamin deficiency type cblG (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Homocystinuria-megaloblastic anemia, cblG type | AR | Biochemical | Medical treatment may be beneficial (while hydroxycobalamin may not be as effective as in other MMA types, other treatments, such as betaine, methylfolate, and even methionine supplements may be attempted) | Biochemical; Cardiovascular; Hematologic; Neurologic; Renal | 2897628; 2203337; 8968736; 8968737; 12068375; 20301503; 22108709 |
ClinVar
This is a list of variants' phenotypes submitted to
- Methylcobalamin_deficiency_type_cblG (976 variants)
- not_provided (125 variants)
- Inborn_genetic_diseases (108 variants)
- Disorders_of_Intracellular_Cobalamin_Metabolism (70 variants)
- not_specified (60 variants)
- MTR-related_disorder (25 variants)
- Neural_tube_defects,_folate-sensitive (18 variants)
- Intellectual_disability (6 variants)
- See_cases (3 variants)
- Homocystinuria (2 variants)
- Decreased_methionine_synthase_activity (2 variants)
- Epilepsy (1 variants)
- Intellectual_disability,_profound (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTR gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000254.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 331 | 344 | ||||
| missense | 10 | 262 | 21 | 300 | ||
| nonsense | 17 | 21 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 34 | 42 | ||||
| splice donor/acceptor (+/-2bp) | 25 | 32 | ||||
| Total | 58 | 48 | 271 | 353 | 10 |
Highest pathogenic variant AF is 0.0005113246
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MTR | protein_coding | protein_coding | ENST00000366577 | 33 | 108672 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.43e-12 | 1.00 | 125655 | 0 | 93 | 125748 | 0.000370 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.04 | 527 | 677 | 0.779 | 0.0000371 | 8317 |
| Missense in Polyphen | 171 | 297.93 | 0.57395 | 3623 | ||
| Synonymous | -0.582 | 259 | 247 | 1.05 | 0.0000145 | 2384 |
| Loss of Function | 4.05 | 31 | 66.7 | 0.465 | 0.00000350 | 852 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000536 | 0.000535 |
| Ashkenazi Jewish | 0.000611 | 0.000595 |
| East Asian | 0.000544 | 0.000544 |
| Finnish | 0.000188 | 0.000185 |
| European (Non-Finnish) | 0.000380 | 0.000378 |
| Middle Eastern | 0.000544 | 0.000544 |
| South Asian | 0.000409 | 0.000392 |
| Other | 0.000654 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transfer of a methyl group from methyl- cobalamin to homocysteine, yielding enzyme-bound cob(I)alamin and methionine. Subsequently, remethylates the cofactor using methyltetrahydrofolate (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Homocystinuria-megaloblastic anemia, cblG complementation type (HMAG) [MIM:250940]: An autosomal recessive inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine. It causes delayed psychomotor development, megaloblastic anemia, homocystinuria, and hypomethioninemia. {ECO:0000269|PubMed:8968736, ECO:0000269|PubMed:8968737}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neural tube defects, folate-sensitive (NTDFS) [MIM:601634]: The most common NTDs are open spina bifida (myelomeningocele) and anencephaly. {ECO:0000269|PubMed:12375236}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Antimetabolite Pathway - Folate Cycle, Pharmacodynamics;One carbon pool by folate - Homo sapiens (human);Cysteine and methionine metabolism - Homo sapiens (human);Selenocompound metabolism - Homo sapiens (human);Methotrexate Pathway (Cancer Cell), Pharmacodynamics;Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics;S-Adenosylhomocysteine (SAH) Hydrolase Deficiency;Methionine Metabolism;Methionine Adenosyltransferase Deficiency;Glycine N-methyltransferase Deficiency;Hypermethioninemia;Methylenetetrahydrofolate Reductase Deficiency (MTHFRD);Betaine Metabolism;Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type;sarcosine oncometabolite pathway ;Cystathionine Beta-Synthase Deficiency;Selenium Micronutrient Network;Vitamin B12 Metabolism;Folate-Alcohol and Cancer Pathway Hypotheses;Folate Metabolism;Trans-sulfuration pathway;One Carbon Metabolism;Trans-sulfuration and one carbon metabolism;Methionine De Novo and Salvage Pathway;One carbon metabolism and related pathways;Ethanol effects on histone modifications;Methylation;Phase II - Conjugation of compounds;Folate metabolism;Metabolism of amino acids and derivatives;Biological oxidations;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism;folate transformations I;Methionine Cysteine metabolism;methionine salvage;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Sulfur amino acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.687
Intolerance Scores
- loftool
- 0.507
- rvis_EVS
- 0.25
- rvis_percentile_EVS
- 69.7
Haploinsufficiency Scores
- pHI
- 0.691
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mtr
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- nervous system development;methionine biosynthetic process;cobalamin metabolic process;axon regeneration;methylation;pteridine-containing compound metabolic process;response to axon injury;cellular response to nitric oxide
- Cellular component
- cytosol
- Molecular function
- protein binding;zinc ion binding;methionine synthase activity;cobalamin binding